Zacks Investment Management Neogenomics Inc Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$14.1 - $19.83 $45,740 - $64,328	3,244 Added 11.32%	31,911 $512,000
Q2 2023 Aug 14, 2023	SELL	$14.1 - $19.83 $138,899 - $195,345	-9,851 Reduced 25.58%	28,667 $460,000
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $245,057 - $524,352	26,959 Added 233.23%	38,518 $670,000
Q4 2022 Feb 14, 2023	BUY	$6.45 - $12.07 $74,555 - $139,517	11,559 New	11,559 $106,000

294

124M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.07B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.